Silva, Erika F <br/><br/>
Decreases in inflammatory and coagulation biomarkers levels in HIV-infected patients switching from enfuvirtide to raltegravir: ANRS 138 substudy.  [electronic resource] 

 -  The Journal of infectious diseases  Sep 2013 
 - 892-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6613 
<br/><br/><label>Standard No.: </label>10.1093/infdis/jit280  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--therapeutic use<br/>Biomarkers--blood<br/>Blood Coagulation--drug effects<br/>C-Reactive Protein--analysis<br/>CD4 Lymphocyte Count<br/>Enfuvirtide<br/>Female<br/>Fibrin Fibrinogen Degradation Products--analysis<br/>HIV Envelope Protein gp41--therapeutic use<br/>HIV Infections--blood<br/>HIV-1<br/>Humans<br/>Inflammation--blood<br/>Interleukin-6--blood<br/>Male<br/>Middle Aged<br/>Peptide Fragments--therapeutic use<br/>Pyrrolidinones--therapeutic use<br/>RNA, Viral--blood<br/>Raltegravir Potassium<br/>Specimen Handling<br/>Viral Load